Status:
TERMINATED
Prevalence and Outcome of Brachial Artery Endothelial Function in Morbidly Obese Patients Undergoing Bariatric Surgery
Lead Sponsor:
Sheba Medical Center
Conditions:
Obesity, Morbid
Ischemic Heart Disease
Eligibility:
All Genders
18-65 years
Brief Summary
The relation between obesity and ischemic heart disease (IHD) is under considerable debate. The reduction in all-cause mortality and, more specifically, the reduction in cardiac-related mortality seen...
Eligibility Criteria
Inclusion
- Morbidly obese patients who fulfill the NIH criteria for surgical intervention.
Exclusion
- Patients deemed unfit for surgery
- Pregnant women, or who are attempting conception.
- Subjects with any history of myocardial infarction, coronary artery bypass grafting surgery, coronary angiography with angioplasty and/or stenting, or any lesion \> 50% of the coronary artery luminal diameter, cerebrovascular accident, or peripheral vascular disease with abnormal electrocardiograms and/or echocardiography.
- History of drug or alcohol abuse.
- Chronic liver disease.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00808652
Start Date
March 1 2009
End Date
November 1 2014
Last Update
May 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Tel Litwinsky, Israel, 52621